METPOD-100DT

4% OFF

Original price was: ₹150.00.Current price is: ₹144.00.

METPOD-100DT

Salt: Cefpodoxime Proxetil 100 mg DT
Brand: Metacine Pharmaceuticals Pvt Ltd

10.0 tablets in 1 strip

Buy Now
Category:

Description

METPOD-100DT is a dispersible oral tablet containing Cefpodoxime Proxetil 100 mg, provided in Alu-Alu blister packaging. It is designed for the treatment of various mild to moderate bacterial infections, especially in patients who have difficulty swallowing whole tablets.

How it Works

Cefpodoxime Proxetil is a third-generation cephalosporin antibiotic. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death for a wide spectrum of gram-positive and gram-negative bacteria responsible for infections.

Main Uses

  • Treatment of respiratory tract infections (pneumonia, bronchitis, sinusitis)

  • Management of ear, nose, throat, and skin infections, as well as urinary tract infections

  • Effective in pediatric and adult patients due to dispersible formulation, allowing easy administration

Key Benefits

  • Rapid relief from symptoms and eradication of infection-causing bacteria

  • Safe dispersible tablet format for children and adults

  • Wide spectrum antibiotic with proven efficacy in various common infections

Dosage & Administration

  • Typical adult dose: 100 mg every 12 hours for 5-10 days, depending on infection and severity

  • Pediatric dosing: 5 mg/kg every 12 hours, maximum dose not to exceed 100 mg per dose for children 2 months to 12 years

  • Tablet should be dispersed in water before administration, taken with or without food as directed

Safety & Precautions

  • Not effective for viral infections

  • Common side effects: nausea, diarrhea, abdominal pain, headache, rash; rare allergic reactions possible

  • Special caution in patients with kidney/liver impairment; consult healthcare provider before use

  • Safe with proper use during pregnancy or breastfeeding if recommended by physician

Leave a Reply

Your email address will not be published. Required fields are marked *